GlassScriptPhysician profile
Bruno R Cotter
NPI 1205886389
$1,250.70
in general payments reported to CMS, 2019-2025
17 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $20.32 · 2021: $28.08 · 2022: $81.65 · 2023: $209 · 2024: $508 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.81 | 2023-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.88 | 2020-2025 | Lifevest |
| Boston Scientific Corporation | $123.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $96.39 | 2023-2024 | |
| Irhythm Technologies, INC. | $80.99 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $78.57 | 2024 | (Ck4) Mcot |
| E.R. Squibb & Sons, L.L.C. | $66.82 | 2024-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $52.86 | 2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $51.81 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $43.42 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $36.90 | 2024 | Arcalyst |
| Amgen INC. | $34.54 | 2024-2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $30.35 | 2025 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $23.19 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $21.21 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.10 | 2024 | Andexxa |
| Janssen Pharmaceuticals, INC | $18.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruno Cotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.